Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Reduction of tuberculosis burden among prisoners in Mongolia: review of case notification, 2001-2010.

Yanjindulam P, Oyuntsetseg P, Sarantsetseg B, Ganzaya S, Amgalan B, Narantuya J, Nishikiori N, Lambregts-van Weezenbeek C.

Int J Tuberc Lung Dis. 2012;16(3):327-9. doi: 10.5588/ijtld.11.0251.

PMID:
22640445
2.

Multidrug-resistant tuberculosis management in resource-limited settings.

Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC.

Emerg Infect Dis. 2006 Sep;12(9):1389-97.

3.

Healthcare workers with tuberculosis infected during work.

de Vries G, Sebek MM, Lambregts-van Weezenbeek CS.

Eur Respir J. 2006 Dec;28(6):1216-21. Epub 2006 Jun 28.

4.

Tuberculosis contact investigation and DNA fingerprint surveillance in The Netherlands: 6 years' experience with nation-wide cluster feedback and cluster monitoring.

Lambregts-van Weezenbeek CS, Sebek MM, van Gerven PJ, de Vries G, Verver S, Kalisvaart NA, van Soolingen D.

Int J Tuberc Lung Dis. 2003 Dec;7(12 Suppl 3):S463-70.

PMID:
14677839
5.

[The tuberculin skin test in the Netherlands: new policies for an old test; guideline from the Netherlands Tuberculosis Control Policy Committee].

Lambregts-van Weezenbeek CS, Cobelens FG, Mensen EA; Commissie voor Praktische Tuberculosebestrijding.

Ned Tijdschr Geneeskd. 2003 Mar 22;147(12):543-6. Dutch.

PMID:
12693082
6.

Increasing transparency in partnerships for health--introducing the Green Light Committee.

Gupta R, Cegielski JP, Espinal MA, Henkens M, Kim JY, Lambregts-Van Weezenbeek CS, Lee JW, Raviglione MC, Suarez PG, Varaine F.

Trop Med Int Health. 2002 Nov;7(11):970-6.

7.

Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group.

Schwoebel V, Lambregts-van Weezenbeek CS, Moro ML, Drobniewski F, Hoffner SE, Raviglione MC, Rieder HL.

Eur Respir J. 2000 Aug;16(2):364-71. Review.

8.

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

Pablos-Méndez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, Cohn DL, Lambregts-van Weezenbeek CS, Kim SJ, Chaulet P, Nunn P.

N Engl J Med. 1998 Jun 4;338(23):1641-9. Erratum in: N England J Med 1998 Jul 9;339(2):139.

9.

Origin and management of primary and acquired drug-resistant tuberculosis in The Netherlands: the truth behind the rates.

Lambregts-van Weezenbeek CS, Jansen HM, Veen J, Nagelkerke NJ, Sebek MM, van Soolingen D.

Int J Tuberc Lung Dis. 1998 Apr;2(4):296-302.

PMID:
9559400
10.

Nationwide surveillance of drug-resistant tuberculosis in The Netherlands: rates, risk factors and treatment outcome.

Lambregts-van Weezenbeek CS, Jansen HM, Nagelkerke NJ, van Klingeren B, Veen J.

Int J Tuberc Lung Dis. 1998 Apr;2(4):288-95.

PMID:
9559399
11.

[Tuberculosis in asylum seekers in The Netherlands].

Kuyvenhoven JV, Lambregts-van Weezenbeek CS, Année-van Bavel JA.

Ned Tijdschr Geneeskd. 1997 Mar 22;141(12):581-4. Dutch.

PMID:
9190525
12.

[Transmission of multiresistant tuberculosis in a Dutch hospital].

Lambregts-van Weezenbeek CS, Keizer ST, Sebek MM, Schepp-Beelen JC, van der Loo CJ.

Ned Tijdschr Geneeskd. 1996 Nov 16;140(46):2293-5. Dutch.

PMID:
8984384
13.

[Transmission of sensitive and resistant strains of Mycobacterium tuberculosis in The Netherlands, 1993-1995, studied by means of DNA fingerprinting].

van Soolingen D, Lambregts-van Weezenbeek CS, de Haas P, Veen J, van Embden JD.

Ned Tijdschr Geneeskd. 1996 Nov 16;140(46):2286-9. Dutch.

PMID:
8984382
14.

[Drug resistance in Mycobacterium tuberculosis in The Netherlands].

Lambregts-van Weezenbeek CS, van Klingeren B, Veen J.

Ned Tijdschr Geneeskd. 1996 Nov 2;140(44):2187-91. Dutch.

PMID:
8984356
15.

Control of drug-resistant tuberculosis.

Lambregts-van Weezenbeek CS, Veen J.

Tuber Lung Dis. 1995 Oct;76(5):455-9.

PMID:
7496009
16.

Ethambutol versus streptomycin during the hospitalized intensive phase of tuberculosis treatment in Benin.

Gninafon M, Lambregts-van Weezenbeek CS, Tawo L, Trebucq A.

Tuber Lung Dis. 1995 Aug;76(4):373-4. No abstract available.

PMID:
7579325

Supplemental Content

Loading ...
Support Center